Vimarsana
Biggest News Aggregation in the World

Geriatric Depression Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Geriatric Depression Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Geriatric Depression Scale Today - Breaking & Trending Today

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial - Vimarsana News

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

Perceived Physical Health Affects Psychotherapy Outcomes in Late-Life Depression - Vimarsana News

Perceived Physical Health Affects Psychotherapy Outcomes in Late-Life Depression

Psychotherapy treatment outcomes for patients with late-life depression are significantly associated with perceived physical health.

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD) | Region - Vimarsana News

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD) | Region

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--Apr 28, 2024--

Depression in Older Adults Accelerates Multimorbidity Progression - Vimarsana News

Depression in Older Adults Accelerates Multimorbidity Progression

Depression in older adults increases the risk for highly complex multimorbidity and is linked to a faster progression of multimorbidity.

Depression in Older Adults Accelerates Multimorbidity Progression - Vimarsana News

Depression in Older Adults Accelerates Multimorbidity Progression

Depression in older adults increases the risk for highly complex multimorbidity and is linked to a faster progression of multimorbidity.